Skip to main content

BioAtla, Inc.

BCAB
Exchange
OTC
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001826892

No open-market purchases or sales by BioAtla, Inc. insiders were filed in the last 90 days; 21 institutions reported holding it in 13F filings for Q2 2026, worth $1.22M in total; no superinvestor holds it.

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by BioAtla, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
0 filings
Open-market sells
0 filings
Insiders trading
0
Net value
$0
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for BioAtla, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for BioAtla, Inc.
NameTitleLast reported holdingLast filingFilings, past year
Sievers EricChief Medical Officer11,346Sep 2, 20265
Short Jay M PhDChief Executive Officer52,035Sep 2, 20265
Vasquez ChristianChief Financial Officer10,476Sep 2, 20265
Waldron Richard AFormer Chief Financial Officer343,421Mar 2, 20262
Steinman LawrenceDirector78,459Jun 18, 20250
Gray Mary AnnDirector77,397Jun 18, 20250
McBrinn SylviaDirector59,125Jun 18, 20250
Smith Scott AndrewDirector321,550Jun 18, 20250
Williams EddieDirector60,200Jun 18, 20250
Moran SusanDirector52,307Jun 18, 20250
Levy GuyOther: Former Director1,115,817IndirectJun 22, 20220
Himalaya Parent LLC10% Owner50Jun 3, 20220

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Jan 19, 2024 (view filing)Mar 28, 2023297 daysLateMcBrinn SylviaDirectorPPurchase+4.00K$2.35+$9.40K+26.4%19.1K after
Dec 26, 2023 (view filing)Dec 26Same dayMcBrinn SylviaDirectorPPurchase+4.00K$2.33+$9.32K+36.0%15.1K after
Dec 20, 2023 (view filing)Dec 20Same dayShort Jay M PhDChief Executive OfficerPPurchase+50.0K$2.14+$107.0K+3.6%1.44M after
Dec 19, 2023 (view filing)Dec 19Same daySteinman LawrenceDirectorPPurchase+20.0K$2.05+$41.0K+108.3%38.5K after
Dec 19, 2023 (view filing)Dec 19Same dayVasquez ChristianSee RemarksPPurchase+7.50K$2.04+$15.3K+6.9%115.7K after
Sep 13, 2023 (view filing)Sep 85 daysLateMcBrinn SylviaDirectorPPurchase+2.00K$2.54+$5.08K+21.9%11.1K after
Mar 30, 2023 (view filing)Mar 291 dayShort Jay M PhDChief Executive OfficerPPurchase+40.8K$2.47+$100.8K+3.0%1.41M after
Mar 29, 2023 (view filing)Mar 281 dayVasquez ChristianSee RemarksPPurchase+20.0K$2.40+$48.0K+24.2%102.7K after
Dec 19, 2022 (view filing)Dec 19Same dayMcBrinn SylviaDirectorPPurchase+3.70K$8.33+$30.8K+68.2%9.13K after
Nov 23, 2022 (view filing)Nov 221 dayMcBrinn SylviaDirectorPPurchase+2.00K$8.27+$16.5K+58.4%5.42K after
Sep 15, 2022 (view filing)Sep 12-133 daysMcBrinn SylviaDirectorPPurchase+3.00K$8.63+$25.9KNew position3.00K afterFrom original2 lots
Aug 15, 2022 (view filing)Aug 123 daysShort Jay M PhDChief Executive OfficerPPurchase+26.4K$7.84+$206.6K+1.9%1.40M after
Jun 23, 2022 (view filing)Jun 21-222 daysShort Jay M PhDChief Executive OfficerPPurchase+69.4K$2.86+$198.4K+5.3%1.38M after2 lots
Jun 9, 2022 (view filing)Jun 7-92 daysVasquez ChristianSee RemarksPPurchase+50.0K$3.02+$150.8K+203.9%74.5K after3 lots
Dec 7, 2021 (view filing)Nov 30-Dec 27 daysLateWaldron Richard AChief Financial OfficerSSale−14.2K$23.48−$333.2K−9.5%134.5K after8 lots
Dec 7, 2021 (view filing)Nov 30-Dec 27 daysLateVasquez ChristianSee RemarksSSale−1.98K$23.48−$46.5K−7.3%25.3K after8 lots
Dec 7, 2021 (view filing)Nov 30-Dec 27 daysLateSmith Scott AndrewPresidentSSale−4.09K$22.27−$91.1K−1.2%345.7K after8 lots
Dec 7, 2021 (view filing)Nov 30-Dec 27 daysLateSievers EricChief Medical OfficerSSale−1.12K$22.27−$25.0K−1.2%91.5K after8 lots
Dec 7, 2021 (view filing)Nov 30-Dec 27 daysLateShort Jay M PhDChief Executive OfficerSSale−47.6K$23.48−$1.12M−3.5%1.32M after8 lots
Dec 6, 2021 (view filing)Nov 297 daysLateWaldron Richard AChief Financial OfficerSSale−4.60K$23.89−$109.9K−3.0%148.7K after
Dec 6, 2021 (view filing)Nov 297 daysLateVasquez ChristianSee RemarksSSale−642$23.89−$15.3K−2.3%27.2K after
Dec 6, 2021 (view filing)Nov 297 daysLateSmith Scott AndrewPresidentSSale−399$23.89−$9.53K−0.1%349.7K after
Dec 6, 2021 (view filing)Nov 297 daysLateSievers EricChief Medical OfficerSSale−110$23.89−$2.63K−0.1%92.6K after
Dec 6, 2021 (view filing)Nov 297 daysLateShort Jay M PhDChief Executive OfficerSSale−15.4K$23.89−$368.7K−1.1%1.37M after
Nov 30, 2021 (view filing)Nov 22-248 daysLateWaldron Richard AChief Financial OfficerSSale−13.3K$25.27−$336.9K−8.0%153.3K after6 lots
Nov 30, 2021 (view filing)Nov 22-248 daysLateVasquez ChristianSee RemarksSSale−2.54K$25.27−$64.2K−8.4%27.9K after6 lots
Nov 30, 2021 (view filing)Nov 22-248 daysLateSmith Scott AndrewPresidentSSale−1.58K$25.27−$39.9K−0.4%350.1K after6 lots
Nov 30, 2021 (view filing)Nov 22-248 daysLateSievers EricChief Medical OfficerSSale−434$25.27−$11.0K−0.5%92.7K after6 lots
Nov 30, 2021 (view filing)Nov 22-248 daysLateShort Jay M PhDChief Executive OfficerSSale−57.6K$25.27−$1.46M−4.0%1.38M after6 lots
Nov 3, 2021 (view filing)Nov 21 daySteinman LawrenceDirectorSSale−450$30.00−$13.5K−2.4%18.5K after
Oct 7, 2021 (view filing)Oct 16 daysLateSmith Scott AndrewPresidentSSale−2.99K$30.18−$90.4K−0.8%351.7K after
Oct 7, 2021 (view filing)Oct 16 daysLateSievers EricChief Medical OfficerSSale−592$30.39−$18.0K−0.6%93.2K after
Sep 17, 2021 (view filing)Sep 152 daysSteinman LawrenceDirectorSSale−450$36.82−$16.6K−2.3%18.9K after
Aug 30, 2021 (view filing)Aug 264 daysSmith Scott AndrewPresidentSSale−33.2K$40.15−$1.33M−8.6%354.7K after2 lots
Aug 30, 2021 (view filing)Aug 264 daysSievers EricChief Medical OfficerSSale−6.88K$39.59−$272.5K−6.8%93.8K after
Aug 26, 2021 (view filing)Aug 242 daysShort Jay M PhDChief Executive OfficerSSale−4.53K$41.60−$188.6K−0.6%793.5K after
Aug 26, 2021 (view filing)Aug 242 daysLevy GuyDirectorSSale−546.7K$39.65−$21.7M−39.2%847.9K after3 lots
Aug 18, 2021 (view filing)Aug 162 daysSteinman LawrenceDirectorSSale−450$40.60−$18.3K−2.3%19.4K after
Jul 19, 2021 (view filing)Jul 154 daysSteinman LawrenceDirectorSSale−450$38.29−$17.2K−2.2%19.8K after